Identifying Key Genes and Drugs for Cervical Cancer Using Bioinformatics
Author Information
Author(s): Talihati Ziruo, Abudurousuli Kayisaier, Hailati Sendaer, Han Mengyuan, Nuer Muhadaisi, Khan Nawaz, Maihemuti Nulibiya, Simayi Jimilihan, Zhang Weiyi, Zhou Wenting
Primary Institution: Xinjiang Medical University, Xinjiang, China
Hypothesis
The study aims to identify novel hub genes associated with traditional Chinese herbs and investigate their underlying mechanisms using bioinformatics analysis combined with experimental verification.
Conclusion
The study identifies six genes as therapeutic targets for cervical cancer and confirms that certain traditional Chinese medicines can induce cell apoptosis.
Supporting Evidence
- Six hub genes were identified: MYC, HIF1A, TP53, STAT3, CCND1, and AKT1.
- Traditional Chinese medicines like quercetin and licochalcone a showed potential in treating cervical cancer.
- Hub genes were linked to the prognosis of cervical cancer patients.
- Statistical analysis indicated significant differences in gene expression between cancerous and normal tissues.
- Experimental validation confirmed the effects of traditional Chinese medicines on gene expression.
Takeaway
Researchers found six important genes that can help treat cervical cancer and showed that some traditional Chinese medicines can kill cancer cells.
Methodology
The study used bioinformatics analysis to identify differentially expressed genes and therapeutic targets, followed by experimental validation.
Limitations
In vivo experiments are needed to validate the findings, and more research is required to confirm precise molecular docking strategies.
Participant Demographics
The study included 12 normal cervical samples and 10 cervical cancer samples.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website